RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
84 hedge funds and large institutions have $382M invested in Rubius Therapeutics, Inc in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-2
Holders Change %
-2.33%
% of All Funds
1.7%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
11
Increased
24
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$11.7M |
| 2 |
Renaissance Technologies
New York
|
$1.33M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$417K |
| 4 |
HF
HRT Financial
New York
|
$230K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$897K |
